OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT00193154 · COMPLETED
Trial details
- NCT number
- NCT00193154
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2004-01-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.